Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss Transplant Cohort Study

Transplant Infectious Disease

Volumn 16, Issue 1, 2014, Pages 26-36

  Bucheli, E ^a   Kralidis, G ^b   Boggian, K ^c   Cusini, A ^d   Garzoni, C ^e   Manuel, O ^f   Meylan, P R A ^f   Mueller, N J ^g   Khanna, N ^a   Van Delden, C ^h   Berger, C ⁱ   Koller, M T ^b   Weisser, M ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Kantonsspital St Gallen   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e Clinica Luganese   (Switzerland)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h GENEVA UNIVERSITY HOSPITALS   (Switzerland)

ⁱ UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Antibiotic resistance; Colonization; Enterococci; Enterococcus faecalis; Enterococcus faecium; Infection; Solid organ transplantation

Indexed keywords

ANTIBIOTIC RESISTANCE; COLONIZATION; ENTEROCOCCI; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; INFECTION; SOLID ORGAN TRANSPLANTATION;

ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; BETA-LACTAMS; COHORT STUDIES; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; FEMALE; GRAFT REJECTION; GRAM-POSITIVE BACTERIAL INFECTIONS; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; ORGAN TRANSPLANTATION; PENICILLIN RESISTANCE; PENICILLINS; PROSPECTIVE STUDIES; RECOMBINANT FUSION PROTEINS; RISK FACTORS; SWITZERLAND; TREATMENT OUTCOME; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84893849061     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12168     Document Type: Article

References (41)

1. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3 (1): 46-65.
2. de Regt MJA, van der Wagen LE, Top J, et al. High acquisition and environmental contamination rates of CC17 ampicillin-resistant Enterococcus faecium in a Dutch hospital. J Antimicrob Chemother 2008; 62 (6): 1401-1406.
3. Iwen PC, Kelly DM, Linder J, et al. Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob Agents Chemother 1997; 41 (2): 494-495.
4. Rice L. Emergence of vancomycin-resistant enterococci. Emerg Infect Dis 2001; 7 (2): 183-187.
5. Werner G, Klare I, Spencker F-B, Witte W. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital. J Antimicrob Chemother 2003; 52 (1): 113-115.
6. Schweizerisches Zentrum für Antibiotikaresistenzen. Available at www.anresis.ch (Accessed 22 February 2012).
7. Freitas M, Pacheco-Silva A, Barbosa D, et al. Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients. BMC Infect Dis 2006; 6 (1): 133.
8. Hagen EA, Lautenbach E, Olthoff K, Blumberg EA. Low prevalence of colonization with vancomycin-resistant Enterococcus in patients awaiting liver transplantation. Am J Transplant 2003; 3 (7): 902-905.
9. Muñoz P; the AST Infectious Diseases Community of Practice. Multiply resistant gram-positive bacteria: vancomycin-resistant Enterococcus in solid organ transplant recipients. Am J Transplant 2009; 9: S50-S56.
10. Patel R, Allen SL, Manahan JM, et al. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transplant 2001; 7 (1): 27-31.
11. Koller MT, van Delden C, Müller NJ, et al. Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort. Eur J Epidemiol 2013; 28 (4): 347-355.
12. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101 (6): 1644-1655.
13. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49 (1): 1-45.
14. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hospital Epidemiol 1992; 13 (10): 606-608.
15. Lee Y, Nelder J. Conditional and marginal models: another view. Stat Sci 2004; 2: 219-228.
16. Rivera-Sanchez R, Delgado-Ochoa D, Flores-Paz R, et al. Prospective study of urinary tract infection surveillance after kidney transplantation. BMC Infect Dis 2010; 10 (1): 245.
17. Snyder JJ, Israni AK, Peng Y, Zhang L, Simon TA, Kasiske BL. Rates of first infection following kidney transplant in the United States. Kidney Int 2008; 75 (3): 317-326.
18. Valdez-Ortiz R, Sifuentes-Osornio J, Morales-Buenrostro LE, et al. Risk factors for infections requiring hospitalization in renal transplant recipients: a cohort study. Int J Infect Dis 2011; 15 (3): e188-e196.
19. Maillard O, Corvec S, Dantal J, et al. Emergence of high ampicillin-resistant Enterococcus faecium isolates in a kidney transplant ward: role of antibiotic pressure and cross transmission. Microb Drug Resist 2010; 16 (2): 123-128.
20. Harthug S, Jureen R, Mohn SC, et al. The prevalence of faecal carriage of ampicillin-resistant and high-level gentamicin-resistant enterococci among inpatients at 10 major Norwegian hospitals. J Hosp Infect 2002; 50 (2): 145-154.
21. Cervera C, Fernández-Ruiz M, Valledor A, et al. Epidemiology and risk factors for late infection in solid organ transplant recipients. Transpl Infect Dis 2011; 13 (6): 598-607.
22. Golebiewska J, Debska-Ślizień A, Komarnicka J, Samet A, Rutkowski B. Urinary tract infections in renal transplant recipients. Transplant Proc 2011; 43 (8): 2985-2990.
23. Asensio A, Ramos A, Cuervas-Mons V, et al. Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant. Liver Transplant 2008; 14 (6): 799-805.
24. Greenland S. Introduction to regression modelling. In: Rothman K, Greenland S, Lash T, eds. Modern Epidemiology. New York: Lippincott-Raven, 2008: 420-421.
25. Leamer E. Specification Searches. New York: Wiley, 1978.
26. R Development Core Team. A Language and Environment for Statistical Computing, 2012. Available at http://www.R-project.org (Accessed May 15, 2012).
27. Iinuma Y, Senda K, Fujihara N, et al. Surgical site infection in living-donor liver transplant recipients: a prospective study. Transplantation 2004; 78 (5): 704-709.
28. Kim YJ, Kim SI, Wie SH, et al. Infectious complications in living-donor liver transplant recipients: a 9-year single-center experience. Transpl Infect Dis 2008; 10 (5): 316-324.
29. Reid GE, Grim SA, Sankary H, Benedetti E, Oberholzer J, Clark NM. Early intra-abdominal infections associated with orthotopic liver transplantation. Transplantation 2009; 87 (11): 1706-1711.
30. Maraha B, Bonten H, Van Hooff H, Fiolet H, Buiting AG, Stobberingh EE. Infectious complications and antibiotic use in renal transplant recipients during a 1-year follow-up. Clin Microbiol Infec 2001; 7 (11): 619-625.
31. Lyerová L, Viklický O, Němcová D, Teplan V. The incidence of infectious diseases after renal transplantation: a single-centre experience. Intl J Antimicrob Agents 2008; 31 (Suppl 1): S58-S62.
32. San Juan R, Aguado JM, Lumbreras C, et al. Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA Study Group. Am J Transplant 2007; 7 (4): 964-971.
33. Gross PA, Harkavy LM, Barden GE, Flower MF. The epidemiology of nosocomial enterococcal urinary tract infection. Am J Med Sci 1976; 272 (1): 75-81.
34. Ruiz-Garbajosa P, de Regt M, Bonten M, et al. High-density fecal Enterococcus faecium colonization in hospitalized patients is associated with the presence of the polyclonal subcluster CC17. Eur J Clin Microbiol Infect Dis 2012; 31 (4): 519-522.
35. Sandiumenge AA, Rello JB. Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management. Curr Opin Pulmonary Med 2012; 18 (3): 187-193.
36. Russell DL, Flood A, Zaroda TE, et al. Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant 2008; 8 (8): 1737-1743.
37. Amari EBE, Hadaya K, Bühler L, et al. Outcome of treated and untreated asymptomatic bacteriuria in renal transplant recipients. Nephrol Dial Transplant 2011; 26 (12): 4109-4114.
38. Novelli A, Mazzei T, Fallani S, Dei R, Cassetta M, Conti S. Betalactam therapy and intestinal flora. J Chemother 1995; 7: 25-31.
39. McNeil SA, Malani PN, Chenoweth CE, et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis 2006; 42 (2): 195-203.
40. Papanicolaou GA, Meyers BR, Meyers J, et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996; 23 (4): 760-766.
41. Abbassi MS, Achour W, Touati A, Ben Hassen A. Enterococcus faecium isolated from bone marrow transplant patients in Tunisia: high prevalence of antimicrobial resistance and low pathogenic power. Pathol Biol 2009; 57 (3): 268-271.